Related Experiment Video
Updated: Mar 13, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
A transdisciplinary framework for managing metabolic dysfunction associated steatotic liver disease
Sania Kouser1, Sanketh V Sharma1, Arun Bhanu1
1Ayurveda Biology and Holistic Nutrition, The University of Transdisciplinary Health Sciences and Technology (TDU), Bengaluru, Karnataka, India.
Abstract:
Metabolic dysfunction-associated steatotic liver disease (MASLD) is rapidly emerging as a public health issue across the globe. Its complex etiopathology and association with diverse comorbidities poses significant challenges to conventional pharmacological drugs derived from the "lock-and-key" paradigm of pharmacology. To overcome the challenges of complexity and non-linear dynamics underlying the disease biology of MASLD, this article proposes a transdisciplinary framework combining holistic disease management principles of traditional medicines with molecular precision of modern biomedicine. Ayurveda - an exceptionally designed and widely practiced Indian Systems of Medicine (ISM) - is explored as a representative model for this framework. This article outlines a unified, biologically plausible transdisciplinary approach incorporating dual-diagnostic workflows, integrative decision interface, and stage-adaptive management algorithm for prevention, early intervention, and advanced disease care. The framework emphasizes integrative and personalized strategies integrating nutrition, lifestyle modification and drug interventions, harnessing the molecular precision of biomedicine alongside the systemic effects of phytochemical diversity. The transdisciplinary model seeks to shift the focus from 'disease treatment' to 'health restoration' and long-term wellness. The article highlights the scopes and challenges of this framework to offer more comprehensive, sustainable, and patient-centred solutions for MASLD.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

